AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Study finds first evidence that PrEP can reduce HIV risk among people who inject drugs

CDC Logo

Daily HIV medications now proven to prevent HIV among all groups at high risk A daily dose of a medication used to treat HIV infection reduced the risk of HIV acquisition among people who inject drugs by 49 percent. Those who took the medication most consistently had even higher levels of protection, according to a…

NIH Scientists Discover How HIV Kills Immune Cells

NIAID

FOR IMMEDIATE RELEASE Wednesday, June 5, 2013 MEDIA AVAILABILITY NIH Scientists Discover How HIV Kills Immune Cells Findings Have Implications for HIV Treatment WHAT: Untreated HIV infection destroys a person’s immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists…

NIDA Research Seeks to Reduce Viral Hepatitis Caused by Drug Use Behaviors

Compton & Khalsa

Hepatitis C virus (HCV) is the leading cause of liver failure and liver transplantation in the United States and people who inject drugs (PWID) are particularly susceptible to this disease with as many as 70% or more of this population testing positive for the virus. To make matters worse, PWID enjoy little if any consistent…

HIV Vaccine Research Update and HVTN 505

HVAD Logo

May 18th was HIV Vaccine Awareness Day, and we wanted to remind you of several posts we did last week on that subject. On Friday, we featured a guest post, Moving Forward on HIV Vaccine Awareness Day, by Dr. Nelson Michael, director of the U.S. Military HIV Research Program. And then we posted this video…

FDA to Convene Meeting on HIV Patient-Focused Drug Development and HIV Cure Research

FDAMeeting

The Food and Drug Administration (FDA) wants to talk to people living with HIV (PLWH) and HIV/AIDS advocates. On June 14, under its Patient-Focused Drug Development initiative, FDA will ask PLWH to join an open public discussion about: the impact of HIV on your daily life, experience with currently available therapies to treat HIV, your…

HIV Vaccine Awareness Day Bulletin

HVAD Logo

The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections — the annual HIV infection rate globally fell by 22 percent from 2001 to 2011 — but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV…

May 18th HIV Vaccine Awareness Day (HVAD): A Conversation with Dr. Carl Dieffenbach

HVAD Logo

May 18th is HIV Vaccine Awareness Day (HVAD), led by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. We spoke to Dr. Carl Dieffenbach at NIH, who had this to say about HIV Vaccine Awareness Day: “[On Vaccine Awareness Day] we can take a moment to acknowledge the…

Statement: NIH Discontinues Immunizations in HIV Vaccine Study

NIAID

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor…